Copies of that antibody are then created in a lab and are known as monoclonal antibodies. These monoclonal antibodies are used to treat some types of cancers, however, can be expensive to produce. For this reason, insurance companies may deny the malignant neoplasm treatment when it includes monoclonal antibodies.